Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study
CONCLUSION: Low baseline NLR and PLR levels are significantly associated with better response in advanced NSCLC patients treated with PD-1/PD-L1 inhibitors, which may be indicators to predict the efficacy of immunotherapy in advanced NSCLC with driver-gene-negative.PMID:38613344 | DOI:10.1177/15330338241246651
Source: Cell Research - Category: Cytology Authors: Qi Yuan Chunhua Xu Wei Wang Qian Zhang Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Genetics | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study